FFPRHC Guidance (October 2004) Contraceptive choices for young people

Menorrhagia and bleeding disorders in adolescent females

In women, von Willebrand disease (VWD) is the most common inherited bleeding disorder. Since VWD and other inherited bleeding disorders are autosomal disorders, they affect women and men. Menorrhagia, or heavy menstrual bleeding (HMB), is the most common symptom of women with bleeding disorder experience. Objectively, it is defined as bleeding that lasts for more than seven days or results in the loss of more than 80 ml of blood per menstrual cycle. The prevalence of menorrhagia in a woman with a bleeding disorder ranges from 32 to 100% in patients with VWD, from 5 to 98% in patients with a platelet dysfunction and from 35 to 70% in women with a rare factor deficiency. A detailed history and a careful physical exam are the first steps towards a diagnosis in adolescents, adding a PBAC>100 increased the sensitivity of the screening tool further to 95%. Laboratory testing should be made at the time of menstrual bleeding in an effort to capture the lowest level of VWF:Ag and FVIII:C. Treatment options for menorrhagia in VWD: (1) antifibrinolytic therapy with tranexamic acid, (2) the non-transfusional agent desmopressin (DDAVP), (3) purified blood products that contain factor VIII and VWF concentrated from plasma and (4) hormonal preparations.

Determinants of multimethod contraceptive use in a sample of adolescent women diagnosed with psychological disorders

Objective. Despite recommendations for concurrent use of contraceptives and condoms to prevent unintended pregnancy and STIs, multimethod contraceptive use among women is poor. This study examined individual-, interpersonal-, and environmental-level factors that predict multimethod use among sexually active adolescent women diagnosed with psychological disorders. Methods. This multisite study analyzed data from 288 sexually active adolescent women who provided sociodemographic, psychosocial, and behavioral data related to birth control and condom use. Results. 34.7% of the participants reported multimethod use in the past three months. Controlling for empirically and theoretically relevant covariates, a multivariable logistic regression identified self-efficacy, multiple partners, pregnancy history, parental communication, parental norms about sex, and neighborhood cohesion as significant predictors of multimethod use. Conclusions. While continued targeted messages about multi-method contraceptive use are imperative at the individual level, an uptake in messages targeting interpersonal- and environmental-level factors such as adolescents' parents and the broader community is urgently needed.

Differences between dual-method and non-dual-method protection use in a sample of young African American women residing in the Southeastern United States

OBJECTIVES

To characterize dual-method protection users and report the prevalence of dual-method use among young adult African American women residing in the Southeastern United States.

DESIGN

Analysis of baseline data from a randomized controlled trial.

SETTING

A clinic-based sample of young women enrolled in a randomized trial of a human immunodeficiency virus (HIV)-prevention program in Atlanta, Georgia, from June 2005 to June 2007.

PARTICIPANTS

African American women aged 14 to 20 years who reported unprotected sexual activity in the past 6 months. Of the eligible adolescents, 94% (N = 701) were enrolled in the study and completed baseline assessments.

OUTCOME MEASURES

Dual-method protection use as well as sociodemographic, individual-level, interpersonal-level, and community-level factors and interpersonal communication skills. Only data from the baseline assessment, before randomization, were used for the analysis.

RESULTS

A total of 102 participants (14.6%) were classified as dual-method protection users. After controlling for age and clinic, significant differences between dual-method users and non-dual-method users were found for impulsivity, self-esteem, social support, relationship style, partner communication self-efficacy, and fear of condom negotiation.

CONCLUSIONS

Dual-method protection use is low. Identification of factors that differentiate dual-method users from non-dual-method users at the individual, interpersonal, and community levels in this young African American sample suggests that HIV, sexually transmitted disease, and unintended pregnancy risk-reduction programs should address factors at each level, not simply the individual level, and that this may involve structural and/or clinical counseling practice changes in clinics that serve young women, to optimally facilitate dual-method protection use among young African American women in the Southeastern United States.

Exploring older adolescents' and young adults' attitudes regarding male hormonal contraception: applications for clinical practice

BACKGROUND

Male hormonal contraceptive methods (HCM) are in Phase I clinical trials in the USA. International studies report that adults have positive attitudes regarding male HCM, but little is known about US minority young peoples' attitudes--a population that experiences high unintended pregnancy rates.

METHODS

Thirty urban African American young persons [50% males; mean age = 18.8 (SD = 2.5)] participated in semi-structured interviews to explore attitudes regarding male HCM. Data were independently analysed by two researchers according to qualitative research methodology, including transcript coding for content, categorization of codes, performance of content analysis for theme development, and corroboration of findings by a third researcher.

RESULTS

The data revealed five major themes that can facilitate and/or hinder male HCM adoption: (1) impact of reversing roles in HCM use; (2) men's lack of involvement in health care; (3) men's reliability to use HCM effectively; (4) perceived responsibility of men who use HCM; and (5) men's apprehension to use new medicines. Overall, participants had positive impressions about male HCM (67% male; 67% female) and female partner trust of males' use was high (85%), as were males' intentions (60%).

CONCLUSIONS

Findings provide a foundation for clinical interventions including: (1) increasing males' involvement in reproductive health; (2) helping males to overcome apprehensions about male HCM safety; and (3) standardizing male HCM education in the clinical setting. Future research efforts should examine whether study findings hold for other populations.